More on SGEN

- Summary
- Chart
- Profile
- Historical


- Earnings (-61.5% Growth)
- Ratings (3.0 Score)
- Holders
- FDA Archive


Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (2/10/16 *Est.)


- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks

SGEN Balance Sheet

Click line-items for a historical chart and %
Cash and cash equivalents 614.07M
Short-term investments
Interest receivable
Accounts receivable 63.5M
Prepaid expenses and other current assets 8.3M
Total current assets 852.77M
Property and equipment, net 44.68M
Long-term investments
Other non-current assets
Total assets 907.34M
Liabilities and Stockholders' Equity
Accounts payable and accrued liabilities
Current portion of deferred revenue 51.51M
Total current liabilities 128.26M
Long-term liabilities
Deferred revenue, less current portion 78.98M
Deferred rent and other long-term liabilities 3.86M
Total long-term liabilities 82.84M
Commitments and contingencies 0
Stockholders' equity
Preferred stock, $0.001 par value, 5,000 shares authorized; none issued and outstanding 0
Common stock, $0.001 par value, 250,000 shares authorized at June 30, 2011 and 150,000 shares authorized at December 31, 2010; 114,419 shares issued and outstanding at June 30, 2011 and 101,607 shares issued and outstanding at December 31, 2010 139K
Additional paid-in capital 1.6B
Accumulated other comprehensive loss 6K
Accumulated deficit -902.07M
Total stockholders' equity 696.24M
Total liabilities and stockholders' equity 907.34M